Trans-brachial artery access for coronary artery procedures is feasible and safe: data from a single-center in Macao

作     者：U Po Lam Edmundo Patricio Lopes Lao Kan Chit Lam Mario Evora Na-Qiong Wu Lam U Po;Lopes Lao Edmundo Patricio;Lam Kan Chit;Evora Mario;Wu Na-Qiong

作者机构：Department of CardiologyCentro Hospital Conde de Sao JanuarioMacaoChina University of MichiganAnn ArborMichigan 48104USA Department of CardiologyCenter of Endocrinology & CardiometabolismNational Center for Cardiovascular DiseasesFuwai HospitalBeijing 100037China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2019年第132卷第12期

页      面：1478-1481页

核心收录：

学科分类：1002[医学-临床医学] 10[医学] 

主　　题：Trans-brachial artery access coronary artery procedures 

摘      要：Compared with trans-femoral artery access (TFA), trans-radial artery access (TRA) for percutaneous coronary interventions (PCI) has been shown to significantly reduce 30-day mortality, in-hospital major adverse cardiac and cardiovascular events (a composite of 30-day mortality and in-hospital myocardial re-infarction, target vessel revascularization, and cerebrovascular events), major bleeding, and access site complications.[1] TRA is more easily compressible, minimizing hematoma risk, and lower crossover rates to another access. Patients may ambulate immediately after procedure, that hospitalization can be shortened significantly. In some centers, patient with TRA can be discharged on the same day of procedure. It is also superior to TFA with closure devices, and becomes the preferred access site for recent PCI.[2]